These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7734359)

  • 21. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
    Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
    Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis.
    Lane DA; Erdjument H; Flynn A; Di Marzo V; Panico M; Morris HR; Greaves M; Dolan G; Preston FE
    Br J Haematol; 1989 Jan; 71(1):91-6. PubMed ID: 2917133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations.
    Aguila S; Navarro-Fernández J; Bohdan N; Gutiérrez-Gallego R; de la Morena-Barrio ME; Vicente V; Corral J; Martínez-Martínez I
    J Thromb Haemost; 2014 Jul; 12(7):1131-40. PubMed ID: 24824609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three novel mutations of antithrombin inducing high-molecular-mass compounds.
    Emmerich J; Vidaud D; Alhenc-Gelas M; Chadeuf G; Gouault-Heilmann M; Aillaud MF; Aiach M
    Arterioscler Thromb; 1994 Dec; 14(12):1958-65. PubMed ID: 7981186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.
    Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V
    J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
    Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The conformational basis of thrombosis.
    Carrell RW; Huntington JA; Mushunje A; Zhou A
    Thromb Haemost; 2001 Jul; 86(1):14-22. PubMed ID: 11487000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow.
    Erdjument H; Lane DA; Panico M; Di Marzo V; Morris HR
    J Biol Chem; 1988 Apr; 263(12):5589-93. PubMed ID: 3162733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombin.
    Emmerich J; Chadeuf G; Coetzee MJ; Alhenc-Gelas M; Fiessinger JN; Aiach M
    Thromb Res; 1994 Nov; 76(3):307-15. PubMed ID: 7863481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
    Brennan SO; Borg JY; Shaw GJ; Caen J; George PM
    Pathology; 1991 Jan; 23(1):1-4. PubMed ID: 2062560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-association of antithrombin III relates to multimer formation of thrombin-antithrombin III complexes.
    Preissner KT
    Thromb Haemost; 1993 May; 69(5):422-9. PubMed ID: 8322264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of antithrombin Barcelona-2: 47 arginine to cysteine.
    Owen MC; Shaw GJ; Grau E; Fontcuberta J; Carrell RW; Boswell DR
    Thromb Res; 1989 Aug; 55(4):451-7. PubMed ID: 2814937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type II antithrombin deficiency caused by a large in-frame insertion: structural, functional and pathological relevance.
    Martínez-Martínez I; Johnson DJ; Yamasaki M; Navarro-Fernández J; Ordóñez A; Vicente V; Huntington JA; Corral J
    J Thromb Haemost; 2012 Sep; 10(9):1859-66. PubMed ID: 22758787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS; Harper PL
    Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.